J-SUPPORT 2201

J-SUPPORT 2201

Study Title Feasibility randomized, placebo-controlled trial of efficacy of midazolam as the second-line treatment for dyspnea in patients with advanced cancer
Principal Investigator/Study Manager/Mentor Masanori Mori /Satoru Miwa /Hiroshi Ishiguro
Condition  
UMIN Clinical Trials Registry  
Funding Source  
Protocol Paper  
Publication  

Spreading effect